Urinary fatty acid biomarkers for prostate cancer detection.
The lack of accuracy in the current prostate specific antigen (PSA) test for prostate cancer (PCa) screening causes around 60-75% of unnecessary prostate biopsies. Therefore, alternative diagnostic methods that have better accuracy and can prevent over-diagnosis of PCa are needed. Researchers have e...
Main Authors: | Elizabeth Noriega Landa, George E Quaye, Xiaogang Su, Sabur Badmos, Kiana L Holbrook, Thomas J Polascik, Eric S Adams, Sriram Deivasigamani, Qin Gao, Michael H Annabi, Ahsan Habib, Wen-Yee Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2024-01-01
|
Series: | PLoS ONE |
Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0297615&type=printable |
Similar Items
-
Evaluation of Recurrent Disease after Radiation Therapy for Patients Considering Local Salvage Therapy: Past vs. Contemporary Management
by: Eric S. Adams, et al.
Published: (2023-12-01) -
The Clinical Applications of Serum and Urinary Biomarkers in Prostate Cancer
by: Renu Eapen, Peter Lonergan, Dominic Bagguley, Sean Ong, Ben Condon, Nathan Lawrentschuck, Maxwell Meng
Published: (2020-10-01) -
The Urinary Transcriptome as a Source of Biomarkers for Prostate Cancer
by: Carla Solé, et al.
Published: (2020-02-01) -
Research of Prostate Cancer Urinary Diagnostic Biomarkers by Proteomics: The Noteworthy Influence of Inflammation
by: Elisa Bellei, et al.
Published: (2023-04-01) -
Commercialized Blood-, Urinary- and Tissue-Based Biomarker Tests for Prostate Cancer Diagnosis and Prognosis
by: Wieke C. H. Visser, et al.
Published: (2020-12-01)